Clinical Trial Update: A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment [Phase 2]

View source ↗

Summary

A Phase II efficacy trial comparing didanosine (ddI) with zidovudine in HIV-infected patients who have been on long-term zidovudine therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• RETROVIR (Zidovudine)
• Videx (didanosine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED